Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 19, Issue 3, pp. 802-811
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 18, 2019
- Revision received September 25, 2019
- Accepted November 25, 2019
- Published first December 3, 2019.
Article Versions
- Previous version (December 3, 2019 - 05:13).
- You are viewing the most recent version of this article.
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Ting Sun1,2,
- Wenjia Zhang1,2,
- Yuan Li1,
- Zhengyu Jin1,
- Yang Du2,3,*,
- Jie Tian2,3,*, and
- Huadan Xue1,*
- 1Department of Radiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
- 2CAS Key Laboratory of Molecular Imaging, The State Key Laboratory of Management and Control for Complex Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, China.
- 3The University of Chinese Academy of Sciences, Beijing, China.
- ↵*Corresponding Authors:
Huadan Xue, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, ShuaiFuYuan No. 1, Wangfujing Street, Dongcheng District, Beijing 100730, China. Phone: 86-10-69155509; E-mail: bjdanna95{at}hotmail.com; Jie Tian, CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China. Phone: 86-10-62527995; Fax: 86-10-62527995; E-mail: jie.tian{at}ia.ac.cn; and Yang Du, CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China. Phone: 86-10-62527995; Fax: 86-10-62527995; E-mail: yang.du{at}ia.ac.cn
March 2020
Volume 19, Issue 3
Volume 19, Issue 3
Combination Immunotherapy with Cytotoxic T-Lymphocyte–Associated Antigen-4 and Programmed Death Protein-1 Inhibitors Prevents Postoperative Breast Tumor Recurrence and Metastasis
Jump to section
Advertisement